BIOMARIN PHARMACEUTICAL INC Increase (Decrease) in Accounts Receivable
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Increase (Decrease) in Accounts Receivable of $46.01 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $38.85M, a 60.58% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $7.16M, a 87.57% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $120.68M.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$48.75M, a 165.54% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in accounts receivable for fiscal 2025 was $228.05M, a 293.81% increase from fiscal 2024.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in accounts receivable for fiscal 2024 was $57.91M, a 69.59% decline from fiscal 2023.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in accounts receivable for fiscal 2023 was $190.44M, a 132.14% increase from fiscal 2022.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in accounts receivable for fiscal 2022 was $82.03M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $38.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $46.01M 10-Q · filed 2026-08-06 | $166.68M derived: sum of 3 quarters · filed 2026-08-06 | $117.94M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $7.16M 10-Q · filed 2026-05-05 | $127.83M derived: sum of 2 quarters · filed 2026-05-05 | $79.09M derived: sum of 3 quarters · filed 2026-05-05 | $177.62M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $120.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $71.93M derived: sum of 2 quarters · filed 2026-02-26 | $170.46M derived: sum of 3 quarters · filed 2026-08-06 | $228.05M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | -$48.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $49.79M derived: sum of 2 quarters · filed 2026-08-06 | $107.38M 10-Q · filed 2025-10-28 | $34.83M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $98.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $156.12M 10-Q · filed 2026-08-06 | $83.58M derived: sum of 3 quarters · filed 2026-08-06 | $157.95M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $57.59M 10-Q · filed 2026-05-05 | -$14.96M derived: sum of 2 quarters · filed 2026-05-05 | $59.42M derived: sum of 3 quarters · filed 2026-05-05 | $112.11M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | -$72.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.83M derived: sum of 2 quarters · filed 2026-02-26 | $54.52M derived: sum of 3 quarters · filed 2026-02-26 | $57.91M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $74.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $127.07M derived: sum of 2 quarters · filed 2025-10-28 | $130.46M 10-Q · filed 2025-10-28 | $188.95M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $52.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $56.08M 10-Q · filed 2025-08-05 | $114.58M derived: sum of 3 quarters · filed 2026-02-26 | $100.69M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $3.39M 10-Q · filed 2025-05-02 | $61.88M derived: sum of 2 quarters · filed 2026-02-26 | $47.99M derived: sum of 3 quarters · filed 2026-02-26 | $55.02M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $58.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $44.60M derived: sum of 2 quarters · filed 2026-02-26 | $51.64M derived: sum of 3 quarters · filed 2026-02-26 | $190.44M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | -$13.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$6.86M derived: sum of 2 quarters · filed 2024-10-31 | $131.94M 10-Q · filed 2024-10-31 | $160.22M derived: sum of 4 quarters · filed 2025-02-24 | ||||
| 2023-06-30 | $7.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $145.83M 10-Q · filed 2024-08-05 | $174.11M derived: sum of 3 quarters · filed 2025-02-24 | $135.30M derived: sum of 4 quarters · filed 2025-02-24 | ||||
| 2023-03-31 | $138.80M 10-Q · filed 2024-04-26 | $167.08M derived: sum of 2 quarters · filed 2025-02-24 | $128.27M derived: sum of 3 quarters · filed 2025-02-24 | $166.02M derived: sum of 4 quarters · filed 2025-02-24 | ||||
| 2022-12-31 | $28.28M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | -$10.53M derived: sum of 2 quarters · filed 2025-02-24 | $27.22M derived: sum of 3 quarters · filed 2025-02-24 | $82.03M 10-K · filed 2025-02-24 | ||||
| 2022-09-30 | -$38.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$1.06M derived: sum of 2 quarters · filed 2023-11-02 | $53.75M 10-Q · filed 2023-11-02 | $53.69M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-06-30 | $37.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $92.56M 10-Q · filed 2023-08-02 | $92.50M derived: sum of 3 quarters · filed 2024-02-26 | $44.41M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-03-31 | $54.81M 10-Q · filed 2023-04-28 | $54.75M derived: sum of 2 quarters · filed 2024-02-26 | $6.66M derived: sum of 3 quarters · filed 2024-02-26 | $29.53M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2021-12-31 | -$61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | -$48.15M derived: sum of 2 quarters · filed 2024-02-26 | -$25.28M derived: sum of 3 quarters · filed 2024-02-26 | -$65.57M 10-K · filed 2024-02-26 | ||||
| 2021-09-30 | -$48.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | -$25.22M derived: sum of 2 quarters · filed 2022-10-28 | -$65.51M 10-Q · filed 2022-10-28 | -$39.39M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-06-30 | $22.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$17.42M 10-Q · filed 2022-08-04 | $8.70M derived: sum of 3 quarters · filed 2023-02-27 | $33.59M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-03-31 | -$40.29M 10-Q · filed 2022-04-29 | -$14.17M derived: sum of 2 quarters · filed 2023-02-27 | $10.71M derived: sum of 3 quarters · filed 2023-02-27 | -$13.16M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2020-12-31 | $26.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $51.01M derived: sum of 2 quarters · filed 2023-02-27 | $27.14M derived: sum of 3 quarters · filed 2023-02-27 | $59.03M 10-K · filed 2023-02-27 | ||||
| 2020-09-30 | $24.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $1.02M derived: sum of 2 quarters · filed 2021-10-29 | $32.91M 10-Q · filed 2021-10-29 | $8.96M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | -$23.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $8.03M 10-Q · filed 2021-07-30 | -$15.92M derived: sum of 3 quarters · filed 2022-02-25 | $14.85M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | $31.90M 10-Q · filed 2021-04-30 | $7.95M derived: sum of 2 quarters · filed 2022-02-25 | $38.72M derived: sum of 3 quarters · filed 2022-02-25 | $18.06M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | -$23.95M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $6.82M derived: sum of 2 quarters · filed 2022-02-25 | -$13.84M derived: sum of 3 quarters · filed 2022-02-25 | $37.85M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $30.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $10.11M derived: sum of 2 quarters · filed 2020-11-06 | $61.80M 10-Q · filed 2020-11-06 | $20.19M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-06-30 | -$20.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $31.03M 10-Q · filed 2020-08-05 | -$10.58M derived: sum of 3 quarters · filed 2021-02-26 | $7.89M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-03-31 | $51.69M 10-Q · filed 2020-05-01 | $10.08M derived: sum of 2 quarters · filed 2021-02-26 | $28.55M derived: sum of 3 quarters · filed 2021-02-26 | $79.71M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2018-12-31 | -$41.61M derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-02-26 | -$23.14M derived: sum of 2 quarters · filed 2021-02-26 | $28.02M derived: sum of 3 quarters · filed 2021-02-26 | $54.27M 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | $18.47M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2019-11-04 | $69.63M derived: sum of 2 quarters · filed 2019-11-04 | $95.88M 10-Q/A · filed 2019-11-04 | $99.54M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | $51.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | $77.42M 10-Q · filed 2019-08-02 | $81.07M derived: sum of 3 quarters · filed 2020-02-27 | $85.84M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | $26.26M 10-Q · filed 2019-04-29 | $29.91M derived: sum of 2 quarters · filed 2020-02-27 | $34.68M derived: sum of 3 quarters · filed 2020-02-27 | $37.46M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $3.66M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $8.42M derived: sum of 2 quarters · filed 2020-02-27 | $11.21M derived: sum of 3 quarters · filed 2020-02-27 | $25.26M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | $4.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $7.55M derived: sum of 2 quarters · filed 2018-10-26 | $21.60M 10-Q · filed 2018-10-26 | $21.06M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-06-30 | $2.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $16.83M 10-Q · filed 2018-08-03 | $16.29M derived: sum of 3 quarters · filed 2019-02-28 | $18.07M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-03-31 | $14.05M 10-Q · filed 2018-04-27 | $13.51M derived: sum of 2 quarters · filed 2019-02-28 | $15.28M derived: sum of 3 quarters · filed 2019-02-28 | $49.49M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2016-12-31 | -$540.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $1.23M derived: sum of 2 quarters · filed 2019-02-28 | $35.44M derived: sum of 3 quarters · filed 2019-02-28 | $51.48M 10-K · filed 2019-02-28 | ||||
| 2016-09-30 | $1.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $35.98M derived: sum of 2 quarters · filed 2017-10-31 | $52.02M 10-Q · filed 2017-10-31 | $68.54M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-06-30 | $34.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $50.25M 10-Q · filed 2017-08-02 | $66.76M derived: sum of 3 quarters · filed 2018-02-26 | $29.03M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-03-31 | $16.04M 10-Q · filed 2017-05-04 | $32.56M derived: sum of 2 quarters · filed 2018-02-26 | -$5.18M derived: sum of 3 quarters · filed 2018-02-26 | $5.62M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2015-12-31 | $16.51M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | -$21.22M derived: sum of 2 quarters · filed 2018-02-26 | -$10.42M derived: sum of 3 quarters · filed 2018-02-26 | $16.37M 10-K · filed 2018-02-26 | ||||
| 2015-09-30 | -$37.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$26.93M derived: sum of 2 quarters · filed 2016-11-03 | -$146.00K 10-Q · filed 2016-11-03 | $22.32M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $10.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $37.59M 10-Q · filed 2016-08-08 | $60.06M derived: sum of 3 quarters · filed 2017-02-27 | $59.15M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $26.79M 10-Q · filed 2016-05-02 | $49.26M derived: sum of 2 quarters · filed 2017-02-27 | $48.36M derived: sum of 3 quarters · filed 2017-02-27 | $60.15M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $22.47M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $21.57M derived: sum of 2 quarters · filed 2017-02-27 | $33.36M derived: sum of 3 quarters · filed 2017-02-27 | $25.95M 10-K · filed 2017-02-27 | $26.65M 10-K · filed 2015-03-02 | |||
| 2014-09-30 | -$902.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $10.89M derived: sum of 2 quarters · filed 2015-11-02 | $3.48M 10-Q · filed 2015-11-02 | $3.57M 10-Q · filed 2014-10-28 | -$3.46M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $11.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $4.38M 10-Q · filed 2015-08-05 | $4.46M 10-Q · filed 2014-07-31 | -$2.56M derived: sum of 3 quarters · filed 2016-02-29 | $7.13M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | -$7.41M 10-Q · filed 2015-05-05 | -$7.36M 10-Q · filed 2014-05-02 | -$14.35M derived: sum of 2 quarters · filed 2016-02-29 | -$4.66M derived: sum of 3 quarters · filed 2016-02-29 | -$9.95M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | -$6.94M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $2.74M derived: sum of 2 quarters · filed 2016-02-29 | -$2.54M derived: sum of 3 quarters · filed 2016-02-29 | $8.74M 10-K · filed 2016-02-29 | $8.76M 10-K · filed 2014-02-26 | |||
| 2013-09-30 | $9.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | $4.40M derived: sum of 2 quarters · filed 2014-10-28 | $15.68M 10-Q · filed 2014-10-28 | $7.46M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-06-30 | -$5.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $6.00M 10-Q · filed 2014-07-31 | -$2.23M derived: sum of 3 quarters · filed 2015-03-02 | $14.31M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-03-31 | $11.28M 10-Q · filed 2014-05-02 | $3.06M derived: sum of 2 quarters · filed 2015-03-02 | $19.59M derived: sum of 3 quarters · filed 2015-03-02 | $14.52M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | -$8.22M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $8.32M derived: sum of 2 quarters · filed 2015-03-02 | $3.24M derived: sum of 3 quarters · filed 2015-03-02 | $4.23M 10-K · filed 2015-03-02 | ||||
| 2012-09-30 | $16.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | $11.46M derived: sum of 2 quarters · filed 2013-10-28 | $12.45M 10-Q · filed 2013-10-28 | $10.43M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2012-06-30 | -$5.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29 | -$4.09M 10-Q · filed 2013-07-29 | -$6.11M derived: sum of 3 quarters · filed 2014-02-26 | -$5.66M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2012-03-31 | $989.00K 10-Q · filed 2013-04-29 | -$1.04M derived: sum of 2 quarters · filed 2014-02-26 | -$585.00K derived: sum of 3 quarters · filed 2014-02-26 | -$177.00K derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2011-12-31 | -$2.02M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | -$1.57M derived: sum of 2 quarters · filed 2014-02-26 | -$1.17M derived: sum of 3 quarters · filed 2014-02-26 | $18.46M 10-K · filed 2014-02-26 | ||||
| 2011-09-30 | $451.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-29 | $859.00K derived: sum of 2 quarters · filed 2012-10-29 | $20.48M 10-Q · filed 2012-10-29 | $28.32M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-06-30 | $408.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $20.03M 10-Q · filed 2012-08-02 | $27.87M derived: sum of 3 quarters · filed 2013-02-26 | $28.92M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-03-31 | $19.62M 10-Q · filed 2012-04-30 | $27.46M derived: sum of 2 quarters · filed 2013-02-26 | $28.52M derived: sum of 3 quarters · filed 2013-02-26 | $23.59M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2010-12-31 | $7.84M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $8.89M derived: sum of 2 quarters · filed 2013-02-26 | $3.97M derived: sum of 3 quarters · filed 2013-02-26 | $13.04M 10-K · filed 2013-02-26 | ||||
| 2010-09-30 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | -$3.87M derived: sum of 2 quarters · filed 2011-10-31 | $5.19M 10-Q · filed 2011-10-31 | $10.36M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-06-30 | -$4.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | $4.14M 10-Q · filed 2011-08-01 | $9.30M derived: sum of 3 quarters · filed 2012-02-22 | $5.11M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-03-31 | $9.07M 10-Q · filed 2011-04-29 | $14.23M derived: sum of 2 quarters · filed 2012-02-22 | $10.03M derived: sum of 3 quarters · filed 2012-02-22 | |||||
| 2009-12-31 | $5.16M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $964.00K derived: sum of 2 quarters · filed 2012-02-22 | $19.24M 10-K · filed 2012-02-22 | |||||
| 2009-09-30 | -$4.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-29 | $14.08M 10-Q · filed 2010-10-29 | ||||||
| 2009-06-30 | $18.28M 10-Q · filed 2010-08-04 | |||||||
| 2008-12-31 | $37.32M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |